Quercis Pharma’s $150 Million Investment Commitment from GEM

Troutman Pepper Hamilton Sanders advised Quercis Pharma on the deal. Quercis Pharma AG (“Quercis”), a private, clinical stage biopharmaceutical company, announced that it has signed a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here